4//SEC Filing
Eiger BioPharmaceuticals, Inc. 4
Accession 0001209191-16-129187
CIK 0001305253operating
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 2:55 PM ET
Size
6.7 KB
Accession
0001209191-16-129187
Insider Transaction Report
Form 4
WELCH JAMES H
Chief Financial Officer
Transactions
- Purchase
Common Stock
2016-06-22$19.79/sh+500$9,897→ 2,500 total - Purchase
Common Stock
2016-06-20$19.80/sh+2,000$39,592→ 2,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.695 to $19.8752, inclusive. The reporting person undertakes to provide to Eiger BioPharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeoperating
Related Parties
1- filerCIK 0001305253
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 2:55 PM ET
- Size
- 6.7 KB